NIH is moving the launch of its new website to the fall to ensure the best possible experience for everyone who relies on our websites for health information, research, funding opportunities, and other resources. Get the Latest Updates and FAQs
Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.
Laser therapy is a safe and effective alternative to eyedrops as afirst-line treatment for patients with newly diagnosed primaryopen-angle glaucoma, according to research results released today.
Results from two years of patient followup in a randomized clinical trial suggest that argon laser therapy may be a safe and effective alternative to eyedrops as a first treatment for patients with newly diagnosed open-angle glaucoma.
Louis W. Sullivan, Secretary of Health and Human Services, has announced results of a clinical trial demonstrating a 50 percent improvement in surgical control of glaucoma in patients at high risk for blindness.